Summary: In this episode, regular guest, Jakob Emerson, Insurance Editor at Becker's Healthcare discusses what payers are currently saying about new weight loss drugs including ozempic and UnitedHealth Group's Optum’s merger with home and hospice care provider Amedisys.
